ralgex 10/1/0.12% %v/v cream
ssl international plc - glycol monosalicylate methyl nicotinate capsicum oleoresin - cream - 10/1/0.12% %v/v
ralgex heat spray 6.0/1.6 %w/v cutaneous spray solution
ssl international plc - glycol monosalicylate methyl nicotinate - cutaneous spray solution - 6.0/1.6 %w/v
ralgex
gr lane health products ltd - glycol monosalicylate ; methyl nicotinate ; capsicum oleoresin - cream - 10/1/0.12% %v/v - other topical products for joint and muscular pain
ralgex heat spray 6.0/1.6 %w/v cutaneous spray solution
gr lane health products ltd - glycol monosalicylate, methyl nicotinate - cutaneous spray solution - 6.0/1.6 %w/v - other topical products for joint and muscular pain
ralgex heat spray
gr lane health products ltd - glycol monosalicylate ; methyl nicotinate - cutaneous spray solution - 6.0/1.6 %w/v - other topical products for joint and muscular pain
ralgex cream 10/1/0.12% %v/v
ssl international plc - glycol monosalicylate methyl nicotinate capsaicin - cream - 10/1/0.12% %v/v
ralgex cream 10/1/0.12 %v/v
eurodrug ltd - glycol monosalicylate methyl nicotinate capsaicin - cream - 10/1/0.12 %v/v
ralgex cream 10/1/0.12 %v/v
boots (uk) limited - glycol monosalicylate methyl nicotinate capsaicin - cream - 10/1/0.12 %v/v
ralgex heat spray
seton products ltd - glycol monosalicylate methyl nicotinate - cutaneous spray solution - 6.0/1.6 %w/v
polyethylene glycol 3350, sodium chloride, sodium bicarbonate and potassium chloride - unflavored powder, for solution polyethy
strides pharma science limited - polyethylene glycol 3350 (unii: g2m7p15e5p) (polyethylene glycol 3350 - unii:g2m7p15e5p), sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698), sodium bicarbonate (unii: 8mdf5v39qo) (sodium cation - unii:lyr4m0nh37, bicarbonate ion - unii:hn1zra3q20), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152, chloride ion - unii:q32zn48698) - polyethylene glycol 3350 420 g in 4 l - polyethylene glycol 3350, sodium chloride, sodium bicarbonate and potassium chloride for oral solution is indicated for bowel cleansing prior to colonoscopy in adults and pediatric patients aged 6 months or greater. polyethylene glycol 3350, sodium chloride, sodium bicarbonate and potassium chloride for oral solution is contraindicated in the following conditions: - gastrointestinal (gi) obstruction, ileus, or gastric retention - bowel perforation - toxic colitis or toxic megacolon - known allergy or hypersensitivity to any component of polyethylene glycol 3350, sodium chloride, sodium bicarbonate and potassium chloride for oral solution [see how supplied/storage and handling (16)] animal reproduction studies have not been conducted with polyethylene glycol 3350, sodium chloride, sodium bicarbonate and potassium chloride for oral solution. it is also not known whether polyethylene glycol 3350, sodium chloride, sodium bicarbonate and potassium chloride for oral solution can cause fetal harm when administered t